PCI Biotech Holding ASA

NEW
OSL:PCIB (Norway)  
kr 1.7 +0.035 (+2.1%) Jul 1
At Loss
P/B:
2.71
Market Cap:
kr 63.45M ($ 6.30M)
Enterprise V:
kr 37.10M ($ 3.68M)
Volume:
27.82K
Avg Vol (2M):
90.43K
Trade In:
Volume:
27.82K
At Loss
Avg Vol (2M):
90.43K

GF Value

PCI Biotech Holding ASA’s share price is kr1.7. Its GF Value is kr0. Based on the relationship between the current stock price and the GF Value, GuruFocus believes PCI Biotech Holding ASA stock is .

The GF Value represents the current intrinsic value of a stock derived from our proprietary algorithm. It is based primarily on the historical multiples of where the stocks have been traded and the future growth of the business, adjusted for the past returns and growth. The GF Value has been verified by backtesting and daily updated model portfolios.

GF Value Growth:

In addition to considering the current valuation, the growth potential of a company's value is equally important. Companies with faster growth rates tend to increase their value more quickly. Therefore, it's essential to look at the Price-to-Future GF Value ratios as well. The results are shown below:

Price: kr1.7 GF Value Price/GF Value
Current kr0 Infinity
Next FY1 End kr0 Infinity
Next 12 Month kr0 Infinity
Next FY2 End kr0 Infinity
Correlation Analysis
Summary:

GuruFocus performed a correlation analysis comparing PCI Biotech Holding ASA's stock price with key financial metrics: revenue per share, book value per share, EPS without NRI, and operating cash flow per share.

The analysis reveals the strongest correlation between PCI Biotech Holding ASA's stock price and Book Value per share, with a coefficient of 93%. PCI Biotech Holding ASA’s stock price shows no significant correlation with Revenue per share. PCI Biotech Holding ASA’s stock price shows no significant correlation with Earnings without NRI per share. PCI Biotech Holding ASA’s stock price shows no significant correlation with Operating Cash Flow per share.

Historical Trends of Key Valuation Ratios
GF Value of Related Companies